Inflammation is associated with incident hypertension in patients with axial spondyloarthritis: A longitudinal cohort study

References

• Berg IJ, Semb AG, van der Heijde D, Kvien TK, Hisdal J, Olsen IC, Dagfinrud H, Provan SA. Uveitis is associated with hypertension and atherosclerosis in patients with ankylosing spondylitis: a cross-sectional study. Semin Arthritis Rheum. 2014;44(3):309–10. doi:10.1016/j.semarthrit.2014.05.017.
   PubMed Web of Science ®Google Scholar
• Lawes CMM, Hoorn SV, Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet. 2008;371(9623):1513–18. doi:10.1016/S0140-6736(08)60655-8.
   PubMed Web of Science ®Google Scholar
• Tam L-S, Tomlinson B, Chu T-W, Li M, Leung Y-Y, Kwok L-W, Li TK, Yu T, Zhu Y-E, Wong K-C, et al. Cardiovascular risk profile of patients with psoriatic arthritis compared to controls—the role of inflammation. Rheumatology. 2008;47(5):718–23. doi:10.1093/rheumatology/ken090.
   PubMed Web of Science ®Google Scholar
• Soltesz P, Kerekes G, Der H, Szucs G, Szanto S, Kiss E, Bodolay E, Zeher M, Timár O, Szodoray P, et al. Comparative assessment of vascular function in autoimmune rheumatic diseases: considerations of prevention and treatment. Autoimmun Rev. 2011;10(7):416–25. doi:10.1016/j.autrev.2011.01.004.
   PubMed Web of Science ®Google Scholar
• Yannoutsos A, Levy BI, Safar ME, Slama G, Blacher J. Pathophysiology of hypertension: interactions between macro and microvascular alterations through endothelial dysfunction. J Hypertens. 2014;32(2):216–24. doi:10.1097/HJH.0000000000000021.
   PubMed Web of Science ®Google Scholar
• Derakhshan MH, Goodson NJ, Packham JC, Sengupta R, Molto A, Marzo-Ortega H, Siebert S. Increased risk of hypertension associated with spondyloarthritis disease duration: results from the ASAS-COMOSPA Study. J Rheumatol. 2019;46(7):701–09. doi:10.3899/jrheum.180538.
   PubMed Web of Science ®Google Scholar
• Zhao SS, Pittam B, Harrison NL, Ahmed AE, Goodson NJ, Hughes DM. Diagnostic delay in axial spondyloarthritis: a systematic review and meta-analysis. Rheumatology. 2021;60(4):1620–28. doi:10.1093/rheumatology/keaa807.
   PubMed Web of Science ®Google Scholar
• Deodhar A, Mease PJ, Reveille JD, Curtis JR, Chen S, Malhotra K, Pangan AL. Frequency of axial spondyloarthritis diagnosis among patients seen by US rheumatologists for evaluation of chronic back pain. Arthritis Rheumatol. 2016;68(7):1669–76. doi:10.1002/art.39612.
   PubMed Web of Science ®Google Scholar
• Liew JW, Ward MM, Reveille JD, Weisman M, Brown MA, Lee M, Rahbar M, Heckbert SR, Gensler LS. Nonsteroidal antiinflammatory drug use and association with incident hypertension in ankylosing spondylitis. Arthritis Care Res (Hoboken). 2020;72(11):1645–52. doi:10.1002/acr.24070.
   PubMed Web of Science ®Google Scholar
• Liew JW, Jafarzadeh SR, Dubreuil M, Heckbert SR, Mooney SJ, Brown MA, Ishimori ML, Reveille JD, Ward MM, Weisman MH, et al. The association of Tumor Necrosis Factor Inhibitor Use with Incident Hypertension in Ankylosing Spondylitis: data from the PSOAS cohort. J Rheumatol. 2022;49(3):274–80. doi:10.3899/jrheum.210332.
   PubMed Web of Science ®Google Scholar
• Shi LH, Lam SH, So H, Li EK, Li TK, Szeto CC, Tam L-S. High inflammatory burden predicts cardiovascular events in patients with axial spondyloarthritis: a long-term follow-up study. Ther Adv Musculoskelet Dis. 2022;14:1759720x221122401. Doi:10.1177/1759720X221122401.
   Web of Science ®Google Scholar
• Rudwaleit M, van der Heijde D, Landewe R, Listing J, Akkoc N, Brandt J, Braun J, Chou CT, Collantes-Estevez E, Dougados M, et al. The development of assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009;68(6):777–83. doi:10.1136/ard.2009.108233.
   PubMed Web of Science ®Google Scholar
• Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the bath ankylosing spondylitis disease activity index. J Rheumatol. 1994;21(12):2286–91.
   PubMed Web of Science ®Google Scholar
• Haroon NN, Paterson JM, Li P, Inman RD, Haroon N. Patients with ankylosing spondylitis have increased cardiovascular and cerebrovascular mortality: a population-based study. Ann Intern Med. 2015;163(6):409–16. doi:10.7326/M14-2470.
   PubMed Web of Science ®Google Scholar
• Eriksson JK, Jacobsson L, Bengtsson K, Askling J. Is ankylosing spondylitis a risk factor for cardiovascular disease, and how do these risks compare with those in rheumatoid arthritis? Ann Rheum Dis. 2017;76(2):364–70. doi:10.1136/annrheumdis-2016-209315.
   PubMed Web of Science ®Google Scholar
• Chaudhary H, Bohra N, Syed K, Donato A, Murad MH, Karmacharya P. All-cause and cause-specific mortality in psoriatic arthritis and ankylosing spondylitis: a systematic review and meta-analysis. Arthritis Care & Research. 2009;68(6):777-83.
   Google Scholar
• Navarini L, Currado D, Marino A, Di Donato S, Biaggi A, Caso F, Costa L, Tasso M, Ruscitti P, Pavlych V, et al. Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritis. Sci Rep. 2022;12(1):7498. doi:10.1038/s41598-022-11640-8.
   PubMed Web of Science ®Google Scholar
• Zhao SS, Robertson S, Reich T, Harrison NL, Moots RJ, Goodson NJ. Prevalence and impact of comorbidities in axial spondyloarthritis: systematic review and meta-analysis. Rheumatol (Oxford). 2020;59(Suppl4):iv47–57. doi:10.1093/rheumatology/keaa246.
   PubMedGoogle Scholar
• Calin A, Garrett S, Whitelock H, Kennedy LG, O’Hea J, Mallorie P, Jenkinson T. A new approach to defining functional ability in ankylosing spondylitis: the development of the bath ankylosing spondylitis functional index. J Rheumatol. 1994;21(12):2281–85.
   PubMed Web of Science ®Google Scholar
• Dougados M, Simon P, Braun J, Burgos-Vargas R, Maksymowych WP, Sieper J, van der Heijde D. ASAS recommendations for collecting, analysing and reporting NSAID intake in clinical trials/epidemiological studies in axial spondyloarthritis. Ann Rheum Dis. 2011;70(2):249–51. doi:10.1136/ard.2010.133488.
   PubMed Web of Science ®Google Scholar
• Ridker PM. A test in context: high-sensitivity c-reactive protein. J Am Coll Cardiol. 2016;67(6):712–23. doi:10.1016/j.jacc.2015.11.037.
   PubMed Web of Science ®Google Scholar
• Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr., et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289(19):2560–72. doi:10.1001/jama.289.19.2560.
   PubMed Web of Science ®Google Scholar
• Chou CH, Lin MC, Peng CL, Wu YC, Sung FC, Kao CH, et al. A nationwide population-based retrospective cohort study: increased risk of acute coronary syndrome in patients with ankylosing spondylitis. Scand J Rheumatol. 2014;43(2):132–36. doi:10.3109/03009742.2013.822097.
   PubMed Web of Science ®Google Scholar
• Spence JD, Grosser T, FitzGerald GA. Acetaminophen, nonsteroidal anti-inflammatory drugs, and hypertension. Hypertension. 2022;79(9):1922–26. doi:10.1161/HYPERTENSIONAHA.122.19315.
   PubMed Web of Science ®Google Scholar
• Brophy S, Cooksey R, Atkinson M, Zhou SM, Husain MJ, Macey S, et al. No increased rate of acute myocardial infarction or stroke among patients with ankylosing spondylitis-a retrospective cohort study using routine data. Semin Arthritis Rheum. 2012;42(2):140–45. doi:10.1016/j.semarthrit.2012.02.008.
   PubMed Web of Science ®Google Scholar
• Bremander A, Petersson IF, Bergman S, Englund M. Population-based estimates of common comorbidities and cardiovascular disease in ankylosing spondylitis. Arthritis Care Res (Hoboken). 2011;63(4):550–56. doi:10.1002/acr.20408.
   PubMed Web of Science ®Google Scholar
• Tekaya AB, Boukriba S, Fendri A, Rouached L, Saidane O, Bouden S, et al. Endothelial dysfunction and increased carotid intima–media thickness in patients with spondyloarthritis without traditional cardiovascular risk factors. RMD Open. 2022;8(2):e002270. doi:10.1136/rmdopen-2022-002270.
   PubMed Web of Science ®Google Scholar
• Verma I, Syngle A, Krishan P, Garg N. Endothelial progenitor cells as a marker of endothelial dysfunction and atherosclerosis in ankylosing spondylitis: a cross-sectional study. Int J Angiol. 2017;26(1):36–42. doi:10.1055/s-0036-1593445.
   PubMedGoogle Scholar
• Demir K, Avcı A, Ergulu Esmen S, Tuncez A, Yalcın MU, Yılmaz A, Yılmaz S, Altunkeser BB. Assessment of arterial stiffness and epicardial adipose tissue thickness in predicting the subclinical atherosclerosis in patients with ankylosing spondylitis. Clin Exp Hypertens. 2021;43(2):169–74. doi:10.1080/10641963.2020.1833025.
   PubMed Web of Science ®Google Scholar
• Vazquez-Agra N, Marques-Afonso AT, Cruces-Sande A, Novo-Veleiro I, Lopez-Paz JE, Pose-Reino A, Hermida-Ameijeiras A. Are differences in inflammatory markers between patients with and without hypertension-mediated organ damage influenced by circadian blood pressure abnormalities? J Clin Med. 2022;11(5):1252. doi:10.3390/jcm11051252.
   PubMed Web of Science ®Google Scholar
• Grosser T, Ricciotti E, FitzGerald GA. The cardiovascular pharmacology of nonsteroidal anti-inflammatory drugs. Trends Pharmacol Sci. 2017;38(8):733–48. doi:10.1016/j.tips.2017.05.008.
   PubMed Web of Science ®Google Scholar
• Cannon CP, Curtis SP, FitzGerald GA, Krum H, Kaur A, Bolognese JA, Reicin AS, Bombardier C, Weinblatt ME, van der Heijde D, et al. Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the multinational etoricoxib and diclofenac arthritis long-term (MEDAL) programme: a randomised comparison. Lancet. 2006;368(9549):1771–81. doi:10.1016/S0140-6736(06)69666-9.
   PubMed Web of Science ®Google Scholar
• Qi Z, Hao CM, Langenbach RI, Breyer RM, Redha R, Morrow JD, Breyer MD. Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II. J Clin Invest. 2002;110(1):61–69. doi:10.1172/JCI0214752.
   PubMed Web of Science ®Google Scholar
• Yang T, Endo Y, Huang YG, Smart A, Briggs JP, Schnermann J. Renin expression in COX-2-knockout mice on normal or low-salt diets. Am J Physiol Renal Physiol. 2000;279(5):F819–25. doi:10.1152/ajprenal.2000.279.5.F819.
   PubMed Web of Science ®Google Scholar
• Whelton A. Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications. Am J Med. 1999;106(5):13S–24S. doi:10.1016/S0002-9343(99)00113-8.
   PubMedGoogle Scholar
• Johnson AG, Nguyen TV. Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis. Ann Intern Med. 1994;121(4):289–300. doi:10.7326/0003-4819-121-4-199408150-00011.
   PubMed Web of Science ®Google Scholar
• van Eijk IC, Peters MJ, Serne EH, van der Horst-Bruinsma IE, Dijkmans BA, Smulders YM, van Eijk IC, van der Horst-Bruinsma IE, Nurmohamed MT. Microvascular function is impaired in ankylosing spondylitis and improves after tumour necrosis factor α blockade. Ann Rheum Dis. 2009;68(3):362–66. doi:10.1136/ard.2007.086777.
   PubMed Web of Science ®Google Scholar
• van Sijl AM, van Eijk IC, Peters MJL, Serne EH, van der Horst-Bruinsma IE, Smulders MJ, van Sijl AM, van Eijk IC, van der Horst-Bruinsma IE, Nurmohamed MT. Tumour necrosis factor blocking agents and progression of subclinical atherosclerosis in patients with ankylosing spondylitis. Ann Rheum Dis. 2015;74(1):119–23. doi:10.1136/annrheumdis-2013-203934.
   PubMed Web of Science ®Google Scholar
• Tam LS, Shang Q, Kun EW, Lee KL, Yip ML, Li M, Li TK, Zhu TY, Pui MO, Li EK, et al. The effects of golimumab on subclinical atherosclerosis and arterial stiffness in ankylosing spondylitis—a randomized, placebo-controlled pilot trial. Rheumatol (Oxford). 2014;53(6):1065–74. doi:10.1093/rheumatology/ket469.
   PubMed Web of Science ®Google Scholar